Clinical Trials Sponsored by Ascenta Therapeutics

Total 6409 results

Ascenta Therapeutics

Completed

Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

Follicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large Cell Lymphoma | Small Lymphocytic Lymphoma

United States
Ascenta Therapeutics

Completed

A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)

Hormone Refractory Prostate Cancer

United States, Russian Federation
Ascenta Therapeutics

Completed

Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma

Follicular Lymphoma

United States
Ascenta Therapeutics

Completed

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Russian Federation, United States, Ukraine
Ascenta Therapeutics

Completed

Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Ascenta Therapeutics

Completed

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

Hormone Refractory Prostate Cancer

United States
Ascenta Therapeutics

Terminated

An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer

Locally Advanced Esophageal or GE Junction Cancer

United States
Ascenta Therapeutics

Completed

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

Prostate Cancer

United States
Ascenta Therapeutics

Completed

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Small Cell Lung Cancer

United States, Russian Federation, Ukraine
ASCEND Therapeutics

Completed

Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women

Cyclic Breast Pain, Cyclic Mastalgia
ASCEND Therapeutics

Completed

Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

Hypogonadism | Low Testosterone | Late Onset Hypogonadism

United States
Memorial Sloan Kettering Cancer Center
Ascenta Therapeutics

Terminated

Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Lung Cancer

United States
University of Alabama at Birmingham
Ascenta Therapeutics

Withdrawn

Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

Carcinoma, Non Small Cell Lung
Ascenta Therapeutics
The Leukemia and Lymphoma Society

Terminated

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia (AML)

United States
ASCEND Therapeutics
Solvay Pharmaceuticals

Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Postmenopausal Symptoms

United States
Dascena

Withdrawn

Trial for the Early Identification of Acute Kidney Injury

Acute Kidney Injury
Dascena

Completed

Respiratory Decompensation and Model for the Triage of COVID-19 Patients (READY)

COVID-19 | Mortality | Coronavirus | Mechanical Ventilation

United States
Dascena

Completed

Effect of a Sepsis Prediction Algorithm on Clinical Outcomes

Severe Sepsis
Dascena

Completed

Classification of COVID-19 Infection in Posteroanterior Chest X-rays

COVID-19

United States
R-Pharm
Ascent

Completed

A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers

Hepatic Impairment

Georgia, Russian Federation
AscentX Medical, Inc.

Recruiting

Bovine Atelocollagen Skin Sensitization Test

Healthy

United States
Ascentia Health, Inc.

Completed

Treatment Outcomes for Temporomandibular Disorders (TMD) Via the Clayton Intra-aural Device (CID) Clinical Trial

Temporomandibular Disorders

Mexico
Dascena

Not yet recruiting

Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment

Sepsis | Septic Shock | Severe Sepsis
Abcentra

Completed

A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors

Coronary Artery Disease | Inflammation | Psoriasis | Cardiometabolic Syndrome

United States
Dascena

Withdrawn

Gram Type Infection-Specific Sepsis Identification Using Machine Learning

Sepsis | Septic Shock | Severe Sepsis
Dascena

Completed

Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning (IDENTIFY)

COVID-19 | Mortality | Coronavirus

United States
Dascena

Completed

COVID-19 Mortality Prediction Model

COVID-19 | Pneumonia | Mechanical Ventilation

United States
University of Southern California
CTI BioPharma; ASCEND Therapeutics

Completed

A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

Advanced Colorectal Cancer

United States
Ascentys Ltd

Not yet recruiting

Feasibility Study of Game Technology in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease (G:DATA)

Dementia Alzheimers

United Kingdom
Accentia Biopharmaceuticals

Completed

Amphotericin B Suspension in Refractory Chronic Sinusitis

Chronic Sinusitis

United States
Acerta Pharma BV
Acerta Pharma, LLC

Completed

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Multiple Myeloma (MM)

United States, United Kingdom
University of Washington
National Institute on Aging (NIA); ASCEND Therapeutics

Completed

Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3] (DHT-3)

Healthy

United States
Ascelia Pharma AB

Completed

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (SPARKLE)

Severe Renal Impairment | Known or Suspected Focal Liver Lesions

United States, Italy, Germany, Poland, Russian Federation, Sweden, Turkey, Argentina, Colombia, Mexico
Ascensia Diabetes Care

Completed

Evaluation of the Performance of CONTOUR NEXT® and CONTOUR PLUS ELITE® BGMS in Neonates Using Capillary Blood Samples

Diabetes Mellitus

United States
Ascensia Diabetes Care

Completed

Evaluation of an Ascensia Diabetes Care Blood Glucose Meter and App System

Diabetes Mellitus

United States
Ascensia Diabetes Care

Completed

Evaluation of an Investigational Blood Glucose Monitoring System

Diabetes

United States
Ascensia Diabetes Care

Completed

A New Glucose Meter With Alternative Site Testing

Diabetes Mellitus

United States
Ascensia Diabetes Care

Completed

Evaluation of DIDGET TM World Reports

Diabetes

United States
Ascensia Diabetes Care

Completed

In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System

Diabetes

United States
Ascensia Diabetes Care

Completed

Study of an Investigational Glucose Meter System

Diabetes

United States
Ascensia Diabetes Care

Completed

Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (ISO/FDA Study)

Diabetes

United States
Ascensia Diabetes Care

Completed

Comparison Evaluation of Blood Glucose Meter Systems in a Clinical Setting

Diabetes

United States
Ascensia Diabetes Care

Completed

Evaluation of an Karajishi TS Investigational Blood Glucose Monitoring System

Diabetes

United States
Axcentua Pharmaceuticals AB

Unknown

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Adenocarcinoma

Sweden
Ascensia Diabetes Care

Completed

Blood Glucose Testing and You

Diabetes

United States
Ascensia Diabetes Care

Completed

Ketostix® and Keto-Diastix® Performance Study

Urinalysis

United States
Ascensia Diabetes Care

Completed

User Performance of the Thunder Plus BGMS

Diabetes Mellitus

United States
Ascensia Diabetes Care

Completed

Evaluation of the Performance of Contour Next® and Contour Plus Elite® BGMS in Arterial Blood Samples From Hospitalized Adults

Diabetes Mellitus

Australia
Ascensia Diabetes Care

Completed

Evaluation of an Ascensia Diabetes Care ONYX PLUS Investigational Blood Glucose Monitoring System

Diabetes

United States
Ascensia Diabetes Care

Completed

Evaluation of a Ascensia ONYX NEXT Investigational Blood Glucose Monitoring System

Diabetes

United States

3

Subscribe